Postpartum Depression: Unmet Needs, Challenges, and Pathophysiology - European Medical Journal

This site is intended for healthcare professionals

Postpartum Depression: Unmet Needs, Challenges, and Pathophysiology

1 Mins
Reproductive Health

Support Statement: This content has been organised and funded by Biogen.
Disclaimer: The webinar is intended for healthcare professionals. 
Disclosure: Apter has been a speaker for Biogen. Jovanović has been a speaker for Biogen and Lundbeck; and has received travel grants from Abbott, Eli Lilly, and Lundbeck.
Acknowledgements: Medical writing assistance was provided by Alena Sofieva, EMJ, London, UK.


In this Biogen-supported Industry Mini Session at the  38th European College of Neuropsychopharmacology (ENCP) Congress, experts Gisèle Apter, Hospital Group Du Havre, Montivilliers; University of Rouen Normandy, Mont-Saint-Aignan, France, and Nikolina Jovanović, Queen Mary University of London, UK, provide a holistic overview of postpartum depression (PPD), its negative consequences, and recognition and management. 

Key topics: 

  • What is PPD, and how common is it?
  • What can we do to detect and manage PPD?
  • How does PPD develop? 
  • What role does the gamma-aminobutyric acid (GABA) system have in PPD? 

Timestamps:

00:00 – Welcome and introductions
03:25 – Unmet Needs and Challenges in PPD
20:59 – Understanding the Pathophysiology of PPD
37:38 – Q&A and Closing Remarks

Speakers:

Gisèle Apter1

Nikolina Jovanović2,3

1. Hospital Group Du Havre, Montivilliers, France
2.
University of Rouen Normandy, Mont-Saint-Aignan, France
3. Queen Mary University of London, UK 

 

 

Biogen-295531 | September 2026

Rate this content's potential impact on patient outcomes

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this content.